Clinical Trials Sponsored by Mario Boccadoro

Total 1075 results

Mario Boccadoro

Active, not recruiting

STUDY THAT COMPARE 3 ARM: MLN9708 DEXAMETHASONE, MLN9708 CYCLOPHOSPHAMIDE AND DEXAMETHASONE, MLN9708 THALIDOMIDE AND DEXAMETHASONE FOLLOWED BY MAINTENANCE WITH MLN9708 IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA PATIENTS

Multiple Myeloma

Italy
Mario Boccadoro

Active, not recruiting

Immune Profiling in Multiple Myeloma

Multiple Myeloma

Italy
Mario Boccadoro

Active, not recruiting

Evaluation of the Safety and the Efficacy of Carfilzomib Combined With Cyclophosphamide and Dexamethasone (CCyd) or Lenalidomide and Dex (CRd) Followed by ASCT or 12 Cycles of Carf Combined With Dex and Len for Patients Eligible for ASCT With Newly Diagnosed Multiple Myeloma. (FORTE)

MULTIPLE MYELOMA (MM)

Italy
Mario Boccadoro

Completed

Validation of a Personalised Medicine Tool for Multiple Myeloma That Predicts Treatment Effectiveness in Patients (MMpredict)

Multiple Myeloma

Italy
Mario Ammirati

Withdrawn

The Evaluation of Clevidipine in Patients Requiring ICP Monitoring and IV Antihypertensive Therapy

Hypertension

United States
Consorzio Mario Negri Sud
LifeScan

Completed

Role Of Self-monitoring of Blood Glucose and Intensive Education in Patients With Type 2 Diabetes Not Receiving Insulin (ROSES)

Type 2 Diabetes

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases (ANTHEM)

Healthy | Autosomal Dominant Polycystic Kidney | Atypical Hemolytic Uremic Syndrome | Membranoproliferative Glomerulonephritis

Italy
Mario Negri Institute for Pharmacological Research

Not yet recruiting

Reduction Of Dietary Salt Intake To Control Systolic Blood Pressure In Hypertensive Older Patients (REPRESS)

Hypertension
Mario Negri Institute for Pharmacological Research

Recruiting

B Cells in Idiopathic Nephrotic Syndrome (BLADE)

Nephrotic Syndrome

Italy
Mario Luca Morieri

Recruiting

Genetic-Dependent Cardiovascular Response to PPAR-Alpha Agonist Fenofibrate (MAGNETIC)

Cardiovascular Diseases | Type 2 Diabetes | Pharmacogenomic Drug Interaction

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Gastric Carcinoma.GOETH Study (GOETH)

Stomach Neoplasms

Italy
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Admissions of Patients Accessing the Emergency Department (ASST Papa Giovanni XXIII)

Emergency Departments | Evaluation | Quality of Care | Appropriateness

Italy
Mario Negri Institute for Pharmacological Research

Completed

Thyroid Hormones in ADPKD (REORIENTED)

Autosomal Dominant Polycystic Kidney

Italy
Mario Negri Institute for Pharmacological Research

Withdrawn

COVID-19 Algorithm Treatment at Home (COVER-HOME)

COVID-19
Mario Negri Institute for Pharmacological Research

Terminated

Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance (MSC-KTX)

Kidney Transplant

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Genetic Study of Nephrolithiasis in Gouty Diathesis

Nephrolithiasis

Italy
Mario Negri Institute for Pharmacological Research

Completed

Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome

Alport Syndrome

Italy
Mario Negri Institute for Pharmacological Research

Completed

A Simple Approach to Prevent Hospitalization for COVID-19 Patients (COVER2)

Covid19

Italy
Mario Negri Institute for Pharmacological Research

Completed

COVID-19 Impact on the Lombardy Region's Emergency System

Covid19

Italy
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Remission Clinic in Proteinuric Chronic Nephropathies

Chronic Kidney Disease

Italy
Mario Negri Institute for Pharmacological Research

Completed

A Simple Approach to Treat COVID-19 Patients at Home. (COVER)

COVID 19

Italy
Mario Negri Institute for Pharmacological Research

Completed

Decision-aid on Breast Cancer Screening

Breast Cancer

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Insulin Treatment in Diabetic Older People With Heart Failure. (Insulin-HF)

Heart Failure | Diabetes Mellitus, Type 2

Italy
Mario Negri Institute for Pharmacological Research

Completed

An Efficacy Study Of Ortataxel In Recurrent Glioblastoma (Ortataxel)

Glioblastoma

Italy
Mario Negri Institute for Pharmacological Research

Completed

E-learning to Improve Oral Anticoagulant Use in Hospitalized Older People With AF (SIM-AF)

Atrial Fibrillation | Elderly | Geriatrics | Simulation Training | Anticoagulant Drugs | Internal Medicine | Drug Prescriptions

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE) (ORCHIDEE)

Renal Cell Carcinoma

Italy
Mario Negri Institute for Pharmacological Research

Completed

Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency (ALADIN2)

Autosomal Dominant Polycystic Kidney Disease

Italy
Mario Negri Institute for Pharmacological Research

Completed

Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain (RER)

Neuropathic Pain | Tumor | Cancer Pain | Breakthrough Cancer Pain

Italy
Mario Negri Institute for Pharmacological Research

Completed

RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the Moment of Starting 3rd Step of WHO Analgesic Ladder. (CERP)

Cancer | Cancer Pain

Italy
Mario Negri Institute for Pharmacological Research

Completed

Multicentric Observational Study on Quality of Life in Glaucoma

Primary Open-angle Glaucoma

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy

Type 2 Diabetes | Early Nephropathy

Italy
Mario Negri Institute for Pharmacological Research

Completed

Intensive Versus Minimal Surveillance of Patients With Resected Dukes B2-C Colorectal Carcinoma (GILDA)

Colorectal Cancer | Surveillance
Consorzio Mario Negri Sud
Artsana SpA

Completed

Efficacy, Safety and Satisfaction of the New Pen Needle 33 Gauge x 4 mm. (AGO01)

Type 1 Diabetes | Type 2 Diabetes

Italy
Mario Negri Institute for Pharmacological Research

Completed

Telmisartan Versus Losartan in Kidney Transplantation (COSTANT)

Renal Transplant

Italy
Mario Negri Institute for Pharmacological Research

Completed

Risk and Prevention Study: Evaluation of the Efficacy of n-3 PUFA in Subjects at High Cardiovascular Risk

Cardiovascular Diseases

Italy
Mario Negri Institute for Pharmacological Research

Completed

Acetylcarnitine and Insulin Sensitivity

Type 2 Diabetes Mellitus

Italy
Mario Negri Institute for Pharmacological Research

Completed

Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant

Kidney Transplant

Italy
Mario Negri Institute for Pharmacological Research

Not yet recruiting

1 vs 7 RATG Infusions in Renal Transplantation (ONSET)

Kidney Replacement

Italy
Mario Negri Institute for Pharmacological Research

Not yet recruiting

An Outcome Analysis of Primary Membranous Nephropathy (PROMENADE)

Membranous Nephropathy

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

New Analytic Tools for aHUS and C3G Diagnosis (COMPRare)

Healthy | Hemolytic-Uremic Syndrome | Membranoproliferative Glomerulonephritis

Italy
Mario Widmer

Recruiting

Effectiveness of a Powered Exoskeleton Combined With FES for Patients With Chronic SCI: a RCT (Ekso-FES)

Spinal Cord Injuries | Gait Disorders, Neurologic

Switzerland
Mario Negri Institute for Pharmacological Research

Recruiting

Severe Acquired Brain Injuries: Prognostic Factors and Quality of Care

Brain Injuries, Acute

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Evaluation of ATRA Activity in Combination With Anastrozole in Pre-operative Phase of Operable Early Breast Cancer (ATRA)

Breast Neoplasm Female

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Autoreactive B Cells in Membranous Nephropathy (PEPTIDE)

Membranous Nephropathy

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Colorectal Carcinoma. CHECK Study. (CHECK)

Colorectal Neoplasms

Italy
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Admissions of Patients Accessing the Emergency Department (Fondazione IRCCS Ca' Granda Ospedale Maggione Policlinico)

Emergency Department | Evaluation | Quality of Care | Appropriateness

Italy
Mario Negri Institute for Pharmacological Research

Completed

Diadem to Investigate the Activity and Safety of Durvalumab (Diadem)

Pleura Mesothelioma

Italy
Mario Negri Institute for Pharmacological Research

Completed

Early CPAP in COVID-19 Patients With Respiratory Failure. (EC-COVID-RCT)

COVID-19 | Emergency Departments | CPAP Ventilation

Italy
Mario Negri Institute for Pharmacological Research

Completed

Early CPAP in COVID-19 Patients With Respiratory Failure. A Prospective Cohort Study. (EC-COVID-PCS)

Early CPAP Ventilation in COVID-19 Patients

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation (RAFTING)

Rheumatoid Arthritis

Italy

Clinical Trials Sponsored by Mario Boccadoro

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Oman

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations